Suvretta Capital Management is an investment management company.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Suvretta Capital Management is an investment management company.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2020 | Molecular Partners | Post-IPO Equity | 0 |
12/2020 | Solid Biosciences | Post-IPO Equity | 0 |
7/2022 | Prokidney | Post-IPO Equity | 205M |
2/2021 | HemoShear Therapeutics | Series A | 40M |
2/2021 | Gemini Therapeutics | Post-IPO Equity | 0 |
12/2021 | Freenome | Series D | 300M |
1/2021 | Terns Pharmaceuticals | Series C | 87M |
7/2021 | Alight Solutions | Post-IPO Equity | 0 |
10/2021 | Roivant Sciences | Post-IPO Equity | 0 |
3/2021 | Paysafe | Post-IPO Equity | 0 |
11/2020 | Ambrx | Private Equity Round | 200M |
6/2021 | Turntide Technologies | Convertible Note | 225M |
2/2021 | Pipeline Therapeutics | Series C | 0 |
7/2021 | Point Biopharma | Post-IPO Equity | 0 |
9/2020 | BioShin | Series A | 60M |
12/2021 | connectRN | Venture Round | 0 |
7/2022 | Prokidney | Post-IPO Equity | 0 |
12/2021 | connectRN | Venture Round | 0 |
12/2021 | Freenome | Series D | 0 |
10/2021 | Roivant Sciences | Post-IPO Equity | 0 |
7/2021 | Alight Solutions | Post-IPO Equity | 0 |
7/2021 | Point Biopharma | Post-IPO Equity | 0 |
6/2021 | Turntide Technologies | Convertible Note | 0 |
3/2021 | Paysafe | Post-IPO Equity | 0 |
2/2021 | Pipeline Therapeutics | Series C | 0 |
2/2021 | HemoShear Therapeutics | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|